[A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections].
Identifieur interne : 004555 ( Main/Exploration ); précédent : 004554; suivant : 004556[A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections].
Auteurs : De-Xian Yu [République populaire de Chine] ; Qing Chen ; Li-Lan Zhang ; Yi Liu ; Zhi-Ai Yu ; Zhi-Feng Li ; Li-Ping Zhang ; Gui-Fang Hu ; Zhao-Jun Duan ; Xin-Wei Chu ; Bin Zhang ; Shou-Yi Yu ; Yun-De HouSource :
- Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology [ 1003-9279 ] ; 2005.
Descripteurs français
- KwdFr :
- Administration par voie nasale, Adulte, Anticorps antiviraux (sang), Antiviraux (administration et posologie), Antiviraux (usage thérapeutique), Humains, Immunoglobuline G (sang), Immunoglobuline M (sang), Infections de l'appareil respiratoire (), Infections de l'appareil respiratoire (sang), Infections de l'appareil respiratoire (virologie), Interféron alpha (administration et posologie), Interféron alpha (usage thérapeutique), Jeune adulte, Méthode en double aveugle, Protéines recombinantes, Résultat thérapeutique, Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (sang), Virus du SRAS (), Virus du SRAS (immunologie).
- MESH :
- administration et posologie : Antiviraux, Interféron alpha.
- immunologie : Virus du SRAS.
- sang : Anticorps antiviraux, Immunoglobuline G, Immunoglobuline M, Infections de l'appareil respiratoire, Syndrome respiratoire aigu sévère.
- usage thérapeutique : Antiviraux, Interféron alpha.
- virologie : Infections de l'appareil respiratoire.
- Administration par voie nasale, Adulte, Humains, Infections de l'appareil respiratoire, Jeune adulte, Méthode en double aveugle, Protéines recombinantes, Résultat thérapeutique, Syndrome respiratoire aigu sévère, Virus du SRAS.
English descriptors
- KwdEn :
- Administration, Intranasal, Adult, Antibodies, Viral (blood), Antiviral Agents (administration & dosage), Antiviral Agents (therapeutic use), Double-Blind Method, Humans, Immunoglobulin G (blood), Immunoglobulin M (blood), Interferon alpha-2, Interferon-alpha (administration & dosage), Interferon-alpha (therapeutic use), Recombinant Proteins, Respiratory Tract Infections (blood), Respiratory Tract Infections (prevention & control), Respiratory Tract Infections (virology), SARS Virus (drug effects), SARS Virus (immunology), Severe Acute Respiratory Syndrome (blood), Severe Acute Respiratory Syndrome (chemically induced), Severe Acute Respiratory Syndrome (prevention & control), Treatment Outcome, Young Adult.
- MESH :
- chemical , administration & dosage : Antiviral Agents, Interferon-alpha.
- chemical , blood : Antibodies, Viral, Immunoglobulin G, Immunoglobulin M.
- chemical , therapeutic use : Antiviral Agents, Interferon-alpha.
- blood : Respiratory Tract Infections, Severe Acute Respiratory Syndrome.
- chemically induced : Severe Acute Respiratory Syndrome.
- drug effects : SARS Virus.
- immunology : SARS Virus.
- prevention & control : Respiratory Tract Infections, Severe Acute Respiratory Syndrome.
- virology : Respiratory Tract Infections.
- Administration, Intranasal, Adult, Double-Blind Method, Humans, Interferon alpha-2, Recombinant Proteins, Treatment Outcome, Young Adult.
Abstract
To study the preventive effect of recombinant human interferon alpha-2b for nasal spray against SARS and other common respiratory viral infections by serum-epidemiological method.
PubMed: 16261200
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002468
- to stream PubMed, to step Curation: 002468
- to stream PubMed, to step Checkpoint: 002392
- to stream Ncbi, to step Merge: 001240
- to stream Ncbi, to step Curation: 001240
- to stream Ncbi, to step Checkpoint: 001240
- to stream Main, to step Merge: 004788
- to stream Main, to step Curation: 004555
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections].</title>
<author><name sortKey="Yu, De Xian" sort="Yu, De Xian" uniqKey="Yu D" first="De-Xian" last="Yu">De-Xian Yu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, The Southern Medical University, Guangzhou 510515, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Epidemiology, The Southern Medical University, Guangzhou 510515</wicri:regionArea>
<placeName><settlement type="city">Jiangmen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chen, Qing" sort="Chen, Qing" uniqKey="Chen Q" first="Qing" last="Chen">Qing Chen</name>
</author>
<author><name sortKey="Zhang, Li Lan" sort="Zhang, Li Lan" uniqKey="Zhang L" first="Li-Lan" last="Zhang">Li-Lan Zhang</name>
</author>
<author><name sortKey="Liu, Yi" sort="Liu, Yi" uniqKey="Liu Y" first="Yi" last="Liu">Yi Liu</name>
</author>
<author><name sortKey="Yu, Zhi Ai" sort="Yu, Zhi Ai" uniqKey="Yu Z" first="Zhi-Ai" last="Yu">Zhi-Ai Yu</name>
</author>
<author><name sortKey="Li, Zhi Feng" sort="Li, Zhi Feng" uniqKey="Li Z" first="Zhi-Feng" last="Li">Zhi-Feng Li</name>
</author>
<author><name sortKey="Zhang, Li Ping" sort="Zhang, Li Ping" uniqKey="Zhang L" first="Li-Ping" last="Zhang">Li-Ping Zhang</name>
</author>
<author><name sortKey="Hu, Gui Fang" sort="Hu, Gui Fang" uniqKey="Hu G" first="Gui-Fang" last="Hu">Gui-Fang Hu</name>
</author>
<author><name sortKey="Duan, Zhao Jun" sort="Duan, Zhao Jun" uniqKey="Duan Z" first="Zhao-Jun" last="Duan">Zhao-Jun Duan</name>
</author>
<author><name sortKey="Chu, Xin Wei" sort="Chu, Xin Wei" uniqKey="Chu X" first="Xin-Wei" last="Chu">Xin-Wei Chu</name>
</author>
<author><name sortKey="Zhang, Bin" sort="Zhang, Bin" uniqKey="Zhang B" first="Bin" last="Zhang">Bin Zhang</name>
</author>
<author><name sortKey="Yu, Shou Yi" sort="Yu, Shou Yi" uniqKey="Yu S" first="Shou-Yi" last="Yu">Shou-Yi Yu</name>
</author>
<author><name sortKey="Hou, Yun De" sort="Hou, Yun De" uniqKey="Hou Y" first="Yun-De" last="Hou">Yun-De Hou</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16261200</idno>
<idno type="pmid">16261200</idno>
<idno type="wicri:Area/PubMed/Corpus">002468</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002468</idno>
<idno type="wicri:Area/PubMed/Curation">002468</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002468</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002392</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002392</idno>
<idno type="wicri:Area/Ncbi/Merge">001240</idno>
<idno type="wicri:Area/Ncbi/Curation">001240</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001240</idno>
<idno type="wicri:doubleKey">1003-9279:2005:Yu D:a:field:trial</idno>
<idno type="wicri:Area/Main/Merge">004788</idno>
<idno type="wicri:Area/Main/Curation">004555</idno>
<idno type="wicri:Area/Main/Exploration">004555</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections].</title>
<author><name sortKey="Yu, De Xian" sort="Yu, De Xian" uniqKey="Yu D" first="De-Xian" last="Yu">De-Xian Yu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, The Southern Medical University, Guangzhou 510515, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Epidemiology, The Southern Medical University, Guangzhou 510515</wicri:regionArea>
<placeName><settlement type="city">Jiangmen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chen, Qing" sort="Chen, Qing" uniqKey="Chen Q" first="Qing" last="Chen">Qing Chen</name>
</author>
<author><name sortKey="Zhang, Li Lan" sort="Zhang, Li Lan" uniqKey="Zhang L" first="Li-Lan" last="Zhang">Li-Lan Zhang</name>
</author>
<author><name sortKey="Liu, Yi" sort="Liu, Yi" uniqKey="Liu Y" first="Yi" last="Liu">Yi Liu</name>
</author>
<author><name sortKey="Yu, Zhi Ai" sort="Yu, Zhi Ai" uniqKey="Yu Z" first="Zhi-Ai" last="Yu">Zhi-Ai Yu</name>
</author>
<author><name sortKey="Li, Zhi Feng" sort="Li, Zhi Feng" uniqKey="Li Z" first="Zhi-Feng" last="Li">Zhi-Feng Li</name>
</author>
<author><name sortKey="Zhang, Li Ping" sort="Zhang, Li Ping" uniqKey="Zhang L" first="Li-Ping" last="Zhang">Li-Ping Zhang</name>
</author>
<author><name sortKey="Hu, Gui Fang" sort="Hu, Gui Fang" uniqKey="Hu G" first="Gui-Fang" last="Hu">Gui-Fang Hu</name>
</author>
<author><name sortKey="Duan, Zhao Jun" sort="Duan, Zhao Jun" uniqKey="Duan Z" first="Zhao-Jun" last="Duan">Zhao-Jun Duan</name>
</author>
<author><name sortKey="Chu, Xin Wei" sort="Chu, Xin Wei" uniqKey="Chu X" first="Xin-Wei" last="Chu">Xin-Wei Chu</name>
</author>
<author><name sortKey="Zhang, Bin" sort="Zhang, Bin" uniqKey="Zhang B" first="Bin" last="Zhang">Bin Zhang</name>
</author>
<author><name sortKey="Yu, Shou Yi" sort="Yu, Shou Yi" uniqKey="Yu S" first="Shou-Yi" last="Yu">Shou-Yi Yu</name>
</author>
<author><name sortKey="Hou, Yun De" sort="Hou, Yun De" uniqKey="Hou Y" first="Yun-De" last="Hou">Yun-De Hou</name>
</author>
</analytic>
<series><title level="j">Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology</title>
<idno type="ISSN">1003-9279</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Intranasal</term>
<term>Adult</term>
<term>Antibodies, Viral (blood)</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Double-Blind Method</term>
<term>Humans</term>
<term>Immunoglobulin G (blood)</term>
<term>Immunoglobulin M (blood)</term>
<term>Interferon alpha-2</term>
<term>Interferon-alpha (administration & dosage)</term>
<term>Interferon-alpha (therapeutic use)</term>
<term>Recombinant Proteins</term>
<term>Respiratory Tract Infections (blood)</term>
<term>Respiratory Tract Infections (prevention & control)</term>
<term>Respiratory Tract Infections (virology)</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (immunology)</term>
<term>Severe Acute Respiratory Syndrome (blood)</term>
<term>Severe Acute Respiratory Syndrome (chemically induced)</term>
<term>Severe Acute Respiratory Syndrome (prevention & control)</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie nasale</term>
<term>Adulte</term>
<term>Anticorps antiviraux (sang)</term>
<term>Antiviraux (administration et posologie)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Humains</term>
<term>Immunoglobuline G (sang)</term>
<term>Immunoglobuline M (sang)</term>
<term>Infections de l'appareil respiratoire ()</term>
<term>Infections de l'appareil respiratoire (sang)</term>
<term>Infections de l'appareil respiratoire (virologie)</term>
<term>Interféron alpha (administration et posologie)</term>
<term>Interféron alpha (usage thérapeutique)</term>
<term>Jeune adulte</term>
<term>Méthode en double aveugle</term>
<term>Protéines recombinantes</term>
<term>Résultat thérapeutique</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (sang)</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiviral Agents</term>
<term>Interferon-alpha</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
<term>Immunoglobulin G</term>
<term>Immunoglobulin M</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
<term>Interferon-alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiviraux</term>
<term>Interféron alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Respiratory Tract Infections</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Respiratory Tract Infections</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Immunoglobuline G</term>
<term>Immunoglobuline M</term>
<term>Infections de l'appareil respiratoire</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Interféron alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections de l'appareil respiratoire</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Intranasal</term>
<term>Adult</term>
<term>Double-Blind Method</term>
<term>Humans</term>
<term>Interferon alpha-2</term>
<term>Recombinant Proteins</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Administration par voie nasale</term>
<term>Adulte</term>
<term>Humains</term>
<term>Infections de l'appareil respiratoire</term>
<term>Jeune adulte</term>
<term>Méthode en double aveugle</term>
<term>Protéines recombinantes</term>
<term>Résultat thérapeutique</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To study the preventive effect of recombinant human interferon alpha-2b for nasal spray against SARS and other common respiratory viral infections by serum-epidemiological method.</div>
</front>
</TEI>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<region><li>Guangdong</li>
</region>
<settlement><li>Jiangmen</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Chen, Qing" sort="Chen, Qing" uniqKey="Chen Q" first="Qing" last="Chen">Qing Chen</name>
<name sortKey="Chu, Xin Wei" sort="Chu, Xin Wei" uniqKey="Chu X" first="Xin-Wei" last="Chu">Xin-Wei Chu</name>
<name sortKey="Duan, Zhao Jun" sort="Duan, Zhao Jun" uniqKey="Duan Z" first="Zhao-Jun" last="Duan">Zhao-Jun Duan</name>
<name sortKey="Hou, Yun De" sort="Hou, Yun De" uniqKey="Hou Y" first="Yun-De" last="Hou">Yun-De Hou</name>
<name sortKey="Hu, Gui Fang" sort="Hu, Gui Fang" uniqKey="Hu G" first="Gui-Fang" last="Hu">Gui-Fang Hu</name>
<name sortKey="Li, Zhi Feng" sort="Li, Zhi Feng" uniqKey="Li Z" first="Zhi-Feng" last="Li">Zhi-Feng Li</name>
<name sortKey="Liu, Yi" sort="Liu, Yi" uniqKey="Liu Y" first="Yi" last="Liu">Yi Liu</name>
<name sortKey="Yu, Shou Yi" sort="Yu, Shou Yi" uniqKey="Yu S" first="Shou-Yi" last="Yu">Shou-Yi Yu</name>
<name sortKey="Yu, Zhi Ai" sort="Yu, Zhi Ai" uniqKey="Yu Z" first="Zhi-Ai" last="Yu">Zhi-Ai Yu</name>
<name sortKey="Zhang, Bin" sort="Zhang, Bin" uniqKey="Zhang B" first="Bin" last="Zhang">Bin Zhang</name>
<name sortKey="Zhang, Li Lan" sort="Zhang, Li Lan" uniqKey="Zhang L" first="Li-Lan" last="Zhang">Li-Lan Zhang</name>
<name sortKey="Zhang, Li Ping" sort="Zhang, Li Ping" uniqKey="Zhang L" first="Li-Ping" last="Zhang">Li-Ping Zhang</name>
</noCountry>
<country name="République populaire de Chine"><region name="Guangdong"><name sortKey="Yu, De Xian" sort="Yu, De Xian" uniqKey="Yu D" first="De-Xian" last="Yu">De-Xian Yu</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004555 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004555 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:16261200 |texte= [A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16261200" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |